We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+5.6%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.36B
AUM Growth
+$69M
Cap. Flow
-$57.7M
Cap. Flow %
-1.72%
Top 10 Hldgs %
15.38%
Holding
1,469
New
124
Increased
451
Reduced
583
Closed
190

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$15M
2
AMZN icon
Amazon
AMZN
+$13.3M
3
NKE icon
Nike
NKE
+$6.91M
4
UNH icon
UnitedHealth
UNH
+$5.87M
5
CMCSA icon
Comcast
CMCSA
+$5.2M

Sector Composition

Rank Sector Weight
1 Healthcare 16.05%
2 Financials 10.83%
3 Consumer Discretionary 9.75%
4 Industrials 9.6%
5 Technology 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIF
76
DELISTED
Tiffany & Co.
TIF
$10.6M 0.32%
139,454
+2,906
+2% +$227K
DUK icon
77
Duke Energy
DUK
$98.4B
$10.5M 0.31%
147,320
+6,828
+5% +$480K
SMCI icon
78
Super Micro Computer
SMCI
$17.9B
$10.4M 0.31%
4,263,140
-160,150
-4% -$418K
NEE icon
79
NextEra Energy
NEE
$183B
$10.2M 0.3%
390,788
-6,240
-2% -$158K
MON
80
DELISTED
Monsanto Co
MON
$9.7M 0.29%
98,421
-18,664
-16% -$1.75M
CMCSA icon
81
Comcast
CMCSA
$84B
$9.62M 0.29%
340,768
+172,600
+103% +$5.2M
F icon
82
Ford
F
$59.3B
$9.34M 0.28%
662,540
+104,559
+19% +$1.51M
EFA icon
83
iShares MSCI EAFE ETF
EFA
$78.5B
$9.32M 0.28%
158,658
+2,476
+2% +$149K
IBB icon
84
iShares Biotechnology ETF
IBB
$9.52B
$9.16M 0.27%
81,237
+1,155
+1% +$125K
UNH icon
85
UnitedHealth
UNH
$383B
$9.02M 0.27%
76,706
+50,183
+189% +$5.87M
CB icon
86
Chubb
CB
$135B
$9.02M 0.27%
77,188
+40,216
+109% +$4.55M
AVHI
87
DELISTED
A V Homes, Inc.
AVHI
$8.87M 0.26%
692,465
+3,515
+0.5% +$46.7K
VLO icon
88
Valero Energy
VLO
$92.6B
$8.85M 0.26%
125,099
+4,782
+4% +$326K
VGK icon
89
Vanguard FTSE Europe ETF
VGK
$30.8B
$8.8M 0.26%
176,414
+35,664
+25% +$1.82M
ESRX
90
DELISTED
Express Scripts Holding Company
ESRX
$8.74M 0.26%
100,039
-4,550
-4% -$390K
WM icon
91
Waste Management
WM
$90.9B
$8.68M 0.26%
162,574
-3,611
-2% -$192K
IWM icon
92
iShares Russell 2000 ETF
IWM
$80.2B
$8.63M 0.26%
76,668
+12,960
+20% +$1.49M
BP icon
93
BP
BP
$114B
$8.45M 0.25%
321,154
+80,163
+33% +$2.28M
FMI
94
DELISTED
Foundation Medicine, Inc.
FMI
$8.38M 0.25%
397,841
+15,500
+4% +$299K
AXP icon
95
American Express
AXP
$228B
$8.35M 0.25%
120,098
-19,002
-14% -$1.38M
CHD icon
96
Church & Dwight Co
CHD
$23.1B
$8.32M 0.25%
196,058
-4,602
-2% -$197K
ELV icon
97
Elevance Health
ELV
$81.6B
$8.15M 0.24%
58,446
-2,791
-5% -$384K
RCI icon
98
Rogers Communications
RCI
$18.4B
$8.11M 0.24%
235,210
-363
-0.2% -$13.6K
COP icon
99
ConocoPhillips
COP
$145B
$8.01M 0.24%
171,571
-19,256
-10% -$1.01M
VFC icon
100
VF Corp
VFC
$5.87B
$7.93M 0.24%
135,261
-36,327
-21% -$2.27M

Similar funds

Oppenheimer & Co's Q4 2015 Portfolio in Review

As of Q4 2015, Oppenheimer & Co held 1,469 positions worth $3.36B, up 2.1% from $3.29B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Oppenheimer & Co's Q4 2015 filing shows 124 new, 451 increased, 583 reduced and 190 closed positions. Its largest new stake was Alphabet (Google) Class A: 405,040 shares worth $15.8M. The largest sale was Alphabet (Google) Class C, an estimated $14.8M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Oppenheimer & Co's largest Q4 2015 buy was Alphabet (Google) Class A: 405,040 shares worth $15.8M.
  • Oppenheimer & Co added most to Amazon in Q4 2015, an estimated $13.3M increase.
  • Oppenheimer & Co's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $14.8M.
  • Oppenheimer & Co fully exited Greenhill & Co., Inc. in Q4 2015, selling an estimated $9.81M.
  • Oppenheimer & Co's ten largest holdings make up 15% of its $3.36B portfolio in Q4 2015.
  • Oppenheimer & Co opened 124 new positions and closed 190 in Q4 2015.
  • Oppenheimer & Co's portfolio value rose 2.1% quarter-over-quarter to $3.36B.

Based on Oppenheimer & Co's 13F filing for Q4 2015, filed 3 Feb 2016.